NEW REPORT: The Heavy Price of GLP-1 Drugs: How Financialization Drives Pharmaceutical Patent Abuse and Health Inequities for GLP-1 Therapies

Our Work
Resources
About Us
Latest
- News & Blog
- Newsletter
Get Involved

News & Blog

Tag: policy blueprint

Oct. 2023: How Egregious Orange Book Manipulation Extended an Insulin Monopoly

Learn more about how you can help build a more equitable system for all

Newsletter
- News & Blog
FAQ
- Contact
Finances and Reporting
- Drug Patent Book

Initiative for Medicines, Access, and Knowledge
16192 Coastal Hwy., Lewes, DE 19958

Except for publications commissioned or published by third parties all content on this site is licensed under a Creative Commons Attribution 3.0 License.

Search for: